Astrazeneca Plc Adr Stock Price History
| AZN Stock | USD 73.55 0.52 0.70% |
Below is the normalized historical share price chart for AstraZeneca PLC ADR extending back to May 12, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of AstraZeneca PLC stands at 73.55, as last reported on the 10th of August, with the highest price reaching 73.90 and the lowest price hitting 73.11 during the day.
If you're considering investing in AstraZeneca Stock, it is important to understand the factors that can impact its price. As of now, AstraZeneca Stock is very steady. AstraZeneca PLC ADR secures Sharpe Ratio (or Efficiency) of 0.0807, which signifies that the company had a 0.0807 % return per unit of risk over the last 3 months. We have found thirty technical indicators for AstraZeneca PLC ADR, which you can use to evaluate the volatility of the firm. Please confirm AstraZeneca PLC's Mean Deviation of 1.23, risk adjusted performance of 0.0498, and Downside Deviation of 1.63 to double-check if the risk estimate we provide is consistent with the expected return of 0.13%.
At this time, AstraZeneca PLC's Total Stockholder Equity is very stable compared to the past year. As of the 10th of August 2025, Liabilities And Stockholders Equity is likely to grow to about 109.2 B, while Common Stock Shares Outstanding is likely to drop about 2.8 B. . As of the 10th of August 2025, Price Earnings To Growth Ratio is likely to grow to 1.58, while Price To Sales Ratio is likely to drop 3.57. AstraZeneca Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of May 1993 | 200 Day MA 70.4491 | 50 Day MA 71.9196 | Beta 0.146 |
AstraZeneca | Build AI portfolio with AstraZeneca Stock |
Sharpe Ratio = 0.0807
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | AZN | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.55 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.13 actual daily | 2 98% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average AstraZeneca PLC is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AstraZeneca PLC by adding it to a well-diversified portfolio.
Price Book 5.0994 | Enterprise Value Ebitda 15.0534 | Price Sales 4.036 | Shares Float 1.5 B | Dividend Share 3.13 |
AstraZeneca PLC Stock Price History Chart
There are several ways to analyze AstraZeneca Stock price data. The simplest method is using a basic AstraZeneca candlestick price chart, which shows AstraZeneca PLC price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | July 30, 2025 | 76.07 |
| Lowest Price | May 14, 2025 | 65.78 |
AstraZeneca PLC August 10, 2025 Stock Price Synopsis
Various analyses of AstraZeneca PLC's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell AstraZeneca Stock. It can be used to describe the percentage change in the price of AstraZeneca PLC from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of AstraZeneca Stock.| AstraZeneca PLC Price Rate Of Daily Change | 0.99 | |
| AstraZeneca PLC Price Action Indicator | (0.22) | |
| AstraZeneca PLC Price Daily Balance Of Power | (0.66) |
AstraZeneca PLC August 10, 2025 Stock Price Analysis
AstraZeneca Stock Price History Data
The price series of AstraZeneca PLC for the period between Mon, May 12, 2025 and Sun, Aug 10, 2025 has a statistical range of 10.29 with a coefficient of variation of 3.01. The prices are distributed with arithmetic mean of 70.77. The median price for the last 90 days is 70.39. The company had 2:1 stock split on 27th of July 2015. AstraZeneca PLC ADR issued dividends on 2025-08-08.| Open | High | Low | Close | Volume | ||
08/10/2025 | 73.47 | 73.90 | 73.11 | 73.55 | ||
| 08/08/2025 | 73.47 | 73.90 | 73.11 | 73.55 | 4,986,256 | |
| 08/07/2025 | 73.29 | 74.09 | 72.95 | 74.07 | 3,427,612 | |
| 08/06/2025 | 74.19 | 74.59 | 72.92 | 73.10 | 2,947,283 | |
| 08/05/2025 | 74.33 | 74.44 | 73.75 | 73.98 | 3,439,695 | |
| 08/04/2025 | 72.83 | 74.09 | 72.72 | 74.08 | 3,513,437 | |
08/01/2025 | 73.05 | 73.62 | 72.84 | 73.45 | 9,803,831 | |
| 07/31/2025 | 74.08 | 75.13 | 72.53 | 72.60 | 8,599,714 | |
07/30/2025 | 75.04 | 76.21 | 74.85 | 76.07 | 10,271,120 | |
07/29/2025 | 72.43 | 74.49 | 72.08 | 73.48 | 14,431,350 | |
07/28/2025 | 72.23 | 72.54 | 71.01 | 71.34 | 7,647,839 | |
07/25/2025 | 72.16 | 72.41 | 71.78 | 72.17 | 6,202,340 | |
| 07/24/2025 | 73.63 | 73.88 | 73.05 | 73.18 | 5,767,090 | |
07/23/2025 | 71.68 | 72.80 | 71.51 | 72.51 | 5,020,773 | |
07/22/2025 | 68.95 | 70.06 | 68.95 | 70.00 | 3,126,719 | |
07/21/2025 | 68.41 | 68.90 | 68.15 | 68.25 | 3,205,456 | |
07/18/2025 | 69.12 | 69.14 | 68.20 | 68.32 | 2,992,178 | |
07/17/2025 | 69.04 | 69.25 | 68.15 | 68.79 | 3,698,668 | |
07/16/2025 | 69.49 | 70.21 | 69.38 | 69.61 | 3,543,031 | |
07/15/2025 | 71.29 | 71.32 | 69.79 | 69.84 | 3,191,976 | |
07/14/2025 | 70.87 | 71.72 | 70.72 | 71.25 | 3,401,875 | |
07/11/2025 | 70.51 | 70.67 | 70.02 | 70.65 | 2,729,868 | |
07/10/2025 | 71.16 | 71.97 | 70.81 | 71.32 | 4,046,703 | |
07/09/2025 | 69.42 | 70.39 | 69.27 | 70.34 | 3,665,539 | |
07/08/2025 | 68.76 | 70.01 | 68.68 | 69.55 | 4,079,718 | |
07/07/2025 | 69.49 | 69.55 | 68.84 | 69.16 | 4,441,675 | |
07/03/2025 | 70.63 | 70.68 | 68.71 | 68.98 | 6,768,010 | |
07/02/2025 | 70.16 | 70.78 | 70.03 | 70.65 | 3,676,175 | |
07/01/2025 | 69.64 | 71.52 | 69.57 | 70.98 | 6,731,078 | |
06/30/2025 | 69.41 | 69.60 | 68.94 | 69.41 | 3,701,686 | |
06/27/2025 | 69.56 | 69.87 | 69.24 | 69.38 | 3,134,832 | |
06/26/2025 | 69.62 | 69.89 | 69.19 | 69.60 | 4,249,711 | |
06/25/2025 | 69.72 | 69.74 | 69.18 | 69.21 | 4,023,466 | |
06/24/2025 | 69.83 | 70.42 | 69.53 | 70.06 | 3,646,781 | |
06/23/2025 | 69.53 | 70.23 | 69.46 | 70.16 | 2,949,832 | |
06/20/2025 | 70.66 | 70.66 | 69.19 | 69.48 | 6,297,122 | |
06/18/2025 | 70.64 | 70.78 | 70.06 | 70.28 | 3,371,567 | |
06/17/2025 | 72.02 | 72.20 | 70.44 | 70.49 | 4,263,587 | |
06/16/2025 | 73.85 | 74.25 | 72.91 | 73.05 | 3,419,053 | |
06/13/2025 | 73.65 | 74.47 | 73.41 | 73.92 | 3,131,593 | |
06/12/2025 | 74.11 | 74.87 | 73.76 | 74.49 | 3,445,758 | |
06/11/2025 | 72.93 | 73.66 | 72.93 | 73.24 | 3,555,427 | |
06/10/2025 | 72.77 | 73.57 | 72.66 | 73.33 | 2,955,796 | |
06/09/2025 | 72.05 | 73.07 | 72.05 | 72.52 | 3,547,424 | |
06/06/2025 | 71.93 | 72.67 | 71.93 | 72.39 | 2,454,022 | |
06/05/2025 | 72.40 | 72.44 | 71.69 | 71.86 | 3,975,003 | |
06/04/2025 | 72.12 | 72.89 | 71.92 | 72.51 | 3,621,090 | |
06/03/2025 | 71.69 | 72.04 | 71.16 | 71.33 | 4,514,607 | |
06/02/2025 | 71.08 | 71.71 | 70.80 | 71.44 | 6,389,992 | |
05/30/2025 | 70.60 | 72.70 | 70.12 | 72.34 | 8,034,278 | |
05/29/2025 | 69.89 | 70.42 | 69.59 | 70.39 | 3,460,905 | |
05/28/2025 | 69.71 | 70.08 | 69.50 | 69.90 | 3,820,839 | |
05/27/2025 | 70.80 | 70.93 | 70.05 | 70.48 | 4,459,256 | |
05/23/2025 | 69.49 | 70.12 | 69.44 | 69.93 | 3,958,322 | |
05/22/2025 | 69.11 | 69.80 | 69.00 | 69.48 | 3,410,127 | |
05/21/2025 | 70.48 | 70.50 | 69.10 | 69.21 | 4,393,517 | |
05/20/2025 | 69.32 | 69.95 | 69.09 | 69.45 | 4,295,161 | |
05/19/2025 | 68.22 | 69.23 | 68.21 | 69.22 | 5,316,051 | |
05/16/2025 | 67.74 | 68.39 | 67.62 | 68.34 | 3,743,327 | |
05/15/2025 | 67.09 | 67.51 | 66.61 | 67.50 | 5,989,876 | |
05/14/2025 | 67.76 | 67.76 | 65.71 | 65.78 | 5,641,348 |
About AstraZeneca PLC Stock history
AstraZeneca PLC investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for AstraZeneca is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in AstraZeneca PLC ADR will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing AstraZeneca PLC stock prices may prove useful in developing a viable investing in AstraZeneca PLC
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.1 B | 2.8 B | |
| Net Income Applicable To Common Shares | 3 B | 3.2 B |
AstraZeneca PLC Stock Technical Analysis
AstraZeneca PLC technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Piotroski F Score Now
Piotroski F ScoreGet Piotroski F Score based on the binary analysis strategy of nine different fundamentals |
| All Next | Launch Module |
AstraZeneca PLC Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for AstraZeneca PLC's price direction in advance. Along with the technical and fundamental analysis of AstraZeneca Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of AstraZeneca to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0498 | |||
| Jensen Alpha | 0.0227 | |||
| Total Risk Alpha | (0.15) | |||
| Sortino Ratio | (0.02) | |||
| Treynor Ratio | 0.155 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.276 | Dividend Share 3.13 | Earnings Share 2.66 | Revenue Per Share | Quarterly Revenue Growth 0.117 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.